-1 : , , , Very comprehensive paper by Dariush Mozaffarian MD DrPH and colleagues published in The American Journal of Clinical Nutrition Very nice summarry of current data on nutritional effects of GLP-1 RAs identification of pragmatic priorities for nutrition and other lifestyle interventions relevant to GLP-1 treatment of obesity for the practicing clinician Priorities to address include: (a) patient-centered initiation of GLP-1s, including goals for weight reduction and health
It involves the direct action of the GLP-1 agonist component on the hearts pacemaker cells, combined with the chronotropic (heart rate-increasing) effects of the glucagon agonist component
doi: 10.1194/jlr.r700019-jlr200 74 LikerB.VranecN.GrbeaD.Baar-HuskiL.MatiI.KneeviM.et al
Carobbio Journal of Hepatology .2026;[Epub] CrossRef Association of metabolic dysfunction-associated steatotic liver disease trajectories with incident liver cancer: a UK Biobank cohort study Ryuk Jun Kwon, Yohwan Lim Frontiers in Endocrinology .2026;[Epub] CrossRef Therapeutic effects and mechanisms of Artemisia species on metabolic diseases: A systematic review Naiyu Wang, Minmin Li, Mingjing Lu, Zheng Wang, Hualin Wang, Meiyue Yao, Hailing Ding, Muhammad Shahbaz, Muhammad Ijaz Medicine .2026
L-carnitine holds a well-established role in treating primary and secondary carnitine deficiencies, conditions where the body cannot produce or utilize carnitine effectively